Kenneth Pace MD, MSc, FRCSC Chief, Division of Urology, St. Michael's Hospital Associate Professor, Department of Surgery, University of Toronto Researcher, Keenan Research Centre, Li Ka Shing Knowledge Institute Adjunct Faculty, Health Policy, Management and Evaluation

Dr. Pace graduated from the Faculty of Medicine at the University of Toronto in 1994. He completed his urology residency in Toronto in 1999, and then completed a Masters degree in Health Research Methodology at McMaster University and a 3-year fellowship in minimally-invasive surgery in 2002.

He joined St. Michael’s Hospital and the faculty of medicine at the University of Toronto in 2002. His practice focuses on laparoscopic and robotic-assisted surgery, the treatment of kidney stones, and kidney transplantation. He performed the first robotic-assisted prostatectomy in Toronto in March, 2007, and has an active practice in robotic-assisted surgery for both prostate and kidney cancer. He has been a leader in minimally-invasive (or laparoscopic) surgery since starting his practice, and has been invited as a lecturer across Canada, the United States, Europe, Australia, and Asia.

His research interests included clinical trials in the treatment of kidney stones and shock wave lithotripsy, as well as quality of life assessment following urologic surgery. He has received peer-reviewed grant funding from the Kidney Foundation of Canada, the Physician Services Incorporated, and the University of Toronto. His research has won best abstract and best presentation awards at meetings of the Canadian Urological Association, American Urological Association, and Endourological Society. He has also won teaching awards for both medical students and residents.

Dr. Pace is the head of division of urology at St. Michael’s Hospital in Toronto. He also serves as co-director of the University of Toronto fellowship program in Urologic Laparoscopy and Endourology, as the University of Toronto Division of Urology Clinical Fellowship Coordinator, as immediate past-president of the Canadian Endourology Group, as the Treasurer of the Northeast Section of the American Urological Association, as Chair and Treasurer of the Canadian Urological Association Scholarship Foundation, and as the immediate Past-President of the Medical Staff Association at St. Michael’s Hospital. He is co-chairman of the 2017 meeting of the World Congress of Endourology, to be held in Vancouver.

Areas of Specialty and Research Interests Robotic surgery, all aspects of advanced urologic laparoscopy, endourology, kidney stones, and renal transplantation

Affiliated Hospital(s) St. Michael's Hospital

If you are looking for local services or  treatment  from your Local Urologist in the office or hospital from a Local Urologist, contact a provider such as ( Dr. Kenneth Pace ) to inquire if they are accepting patients or you need a referral.   Phone number to book an appointment (416) 867-3695

The speaker in the video may have no association with ( Dr. Kenneth Pace, Local Urologist Toronto, ON ). 
( Dr. Kenneth Pace, Local Urologist Toronto, ON ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist about the information you learnt from the videos in regards to treatments and procedures the Local Urologist could  perform and if they would be appropriate for you. Remember good information is the corner stone to understanding your condition or disease. Please contact ( Dr. Kenneth Pace, Local Urologist Toronto, ON ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal  conditions

Urology Information: 

Depending on the case, prostate cancer may be safely followed with active surveillance or watchful waiting rather than surgery, chemotherapy or radiation. Ask your local urologist for more information on Contino®, an alternative to diapers or surgery. Patients may be referred to a urologist if their physician suspects they may need treatment for a condition relating to bladder, urethra, ureters, kidneys, and adrenal glands.

Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Depending on the case, prostate cancer may be safely followed with active surveillance or watchful waiting rather than surgery, chemotherapy or radiation. Prostate cancer is the most common cancer in Canadian men. It is most common in older men

Colorectal ; Other Cancers: Dietary fibre and antioxidant intake are two of the biggest considerations
when it comes to reducing the risk of preventable cancers, such as colorectal cancer. Beets and beet
greens are among the most abundant sources of both these important nutrients.

Your body will digest and absorb short-chain carbohydrates (also called rapid-acting carbohydrates) more quickly, which can actually cause a spike in the blood sugar. Some examples would be juice, white bread and sugar. Longer-chain carbohydrates take the body longer to digest and absorb, causing less of an effect on the blood sugar. Examples are legumes, oats, barley and berries. These carbohydrates can play a very important role in diabetes management. 

Surgery for prostate cancer is called a radical prostatectomy and involves the removal of the prostate gland with or without some lymph nodes in the pelvis. This can be performed with key-hole surgery called laparoscopy (usually done with a robot to help the surgeon) or through a small incision in the lower part of the abdomen called open surgery.

Once prostate cancer is diagnosed, one of the first things doctors do is determine how aggressive cancers are (also known as tumor grade) and how much of the prostate is involved and if the cancer has spread outside of the gland to nearby tissues or other parts of the body (otherwise known as tumor stage). This information is important to help determine the treatment options for men newly diagnosed with prostate cancer. What is tumor Grade?:

When a tumor is discovered on prostate biopsy, the aggressiveness of the cancer can be classified into a category called tumor grade. In general, the higher the grade, the more aggressive cancers are. In prostate cancer, the grade is most commonly described as a Gleason Score. The Gleason Score of a prostate cancer is between 2-10. Scores 6 or less are considered mildly aggressive, 7 is considered intermediate aggressive, and scores 8-10 are considered very aggressive. In summary, the higher the Gleason Score, the more aggressive the cancer is, and the greater the risk of cancer spreading outside of the prostate gland. What is tumor Stage?: Often seeing a local urologist in Toronto can help.